Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
for the IOF-IFCC Bone Marker Standards Working Group(The University of Western Australia), Samuel D Vasikaran(Royal Perth Hospital), Richard Eastell(University of Liège), Olivier Bruyère(University of Liège), A. Joseph Foldes(Inserm), Patrick Garnero(Inserm), Andrea Griesmacher(Bone Health and Osteoporosis Foundation), Michael R. McClung(University of South Australia), Howard A. Morris(Cedars-Sinai Medical Center), Stuart L. Silverman(Cedars-Sinai Medical Center), Tommaso Trenti, D. A. Wahl(Southampton General Hospital), Cyrus Cooper(Southampton General Hospital), J. A. Kanis(University of Sheffield)
Cited by 1,165
Abstract
Related Papers
Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents
Marc C. Hochberg, Susan L. Greenspan, Richard D. Wasnich et al.|The Journal of Clinical Endocrinology & Metabolism|2002|454
Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis
Peiqi Chen, Julie Satterwhite, Angelo A. Licata et al.|Journal of Bone and Mineral Research|2005|309